| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Activin receptor type-2B |
|---|
| Ligand | BDBM31099 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Kinase Inhibitor Selectivity Profiling Assay |
|---|
| Kd | 2400±n/a nM |
|---|
| Citation |  PubChem, PC Kinase Inhibitor Selectivity Profiling Assay PubChem Bioassay(2008)[AID] |
|---|
| More Info.: | Get all data from this article, Solution Info, Assay Method |
|---|
| |
| Activin receptor type-2B |
|---|
| Name: | Activin receptor type-2B |
|---|
| Synonyms: | ACVR2B | AVR2B_HUMAN | Activin receptor type-2B |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 57713.76 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | gi_116734708 |
|---|
| Residue: | 512 |
|---|
| Sequence: | MTAPWVALALLWGSLCAGSGRGEAETRECIYYNANWELERTNQSGLERCEGEQDKRLHCY
ASWRNSSGTIELVKKGCWLDDFNCYDRQECVATEENPQVYFCCCEGNFCNERFTHLPEAG
GPEVTYEPPPTAPTLLTVLAYSLLPIGGLSLIVLLAFWMYRHRKPPYGHVDIHEDPGPPP
PSPLVGLKPLQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMK
HENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSY
LHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVG
TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQ
HPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERVSL
IRRSVNGTTSDCLVSLVTSVTNVDLPPKESSI
|
|
|
|---|
| BDBM31099 |
|---|
| n/a |
|---|
| Name | BDBM31099 |
|---|
| Synonyms: | 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S)-3-hydroxy-1-methyl-4-piperidinyl]-1-benzopyran-4-one | 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S)-3-hydroxy-1-methyl-4-piperidyl]chromone | 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one | 2-(2-chlorophenyl)-8-[(3S)-1-methyl-3-oxidanyl-piperidin-4-yl]-5,7-bis(oxidanyl)chromen-4-one | CHEMBL45741 | Flavopiridol | cid_24867231 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C21H20ClNO5 |
|---|
| Mol. Mass. | 401.84 |
|---|
| SMILES | CN1CCC([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl |
|---|
| Structure | 
|
|---|
Search and Browse
